Clinical Usefulness of Serum Antip53 Antibodies for Prostate Cancer Detection:: A Comparative Study With Prostate Specific Antigen Parameters

  • HIROYOSHI SUZUKI
    From the Departments of Urology (HSu, KA, TI, TU, HI), Laboratory and Clinical Medicine (FN) and Academic Surgery (TO, HSh), Graduate School of Medicine, Chiba University, Chiba and Department of Pathology, Faculty of Medicine, Mie University (MW), Mie, Japan
  • KOICHIRO AKAKURA
    From the Departments of Urology (HSu, KA, TI, TU, HI), Laboratory and Clinical Medicine (FN) and Academic Surgery (TO, HSh), Graduate School of Medicine, Chiba University, Chiba and Department of Pathology, Faculty of Medicine, Mie University (MW), Mie, Japan
  • TATSUO IGARASHI
    From the Departments of Urology (HSu, KA, TI, TU, HI), Laboratory and Clinical Medicine (FN) and Academic Surgery (TO, HSh), Graduate School of Medicine, Chiba University, Chiba and Department of Pathology, Faculty of Medicine, Mie University (MW), Mie, Japan
  • TAKESHI UEDA
    From the Departments of Urology (HSu, KA, TI, TU, HI), Laboratory and Clinical Medicine (FN) and Academic Surgery (TO, HSh), Graduate School of Medicine, Chiba University, Chiba and Department of Pathology, Faculty of Medicine, Mie University (MW), Mie, Japan
  • HARUO ITO
    From the Departments of Urology (HSu, KA, TI, TU, HI), Laboratory and Clinical Medicine (FN) and Academic Surgery (TO, HSh), Graduate School of Medicine, Chiba University, Chiba and Department of Pathology, Faculty of Medicine, Mie University (MW), Mie, Japan
  • MASATOSHI WATANABE
    From the Departments of Urology (HSu, KA, TI, TU, HI), Laboratory and Clinical Medicine (FN) and Academic Surgery (TO, HSh), Graduate School of Medicine, Chiba University, Chiba and Department of Pathology, Faculty of Medicine, Mie University (MW), Mie, Japan
  • FUMIO NOMURA
    From the Departments of Urology (HSu, KA, TI, TU, HI), Laboratory and Clinical Medicine (FN) and Academic Surgery (TO, HSh), Graduate School of Medicine, Chiba University, Chiba and Department of Pathology, Faculty of Medicine, Mie University (MW), Mie, Japan
  • TAKENORI OCHIAI
    From the Departments of Urology (HSu, KA, TI, TU, HI), Laboratory and Clinical Medicine (FN) and Academic Surgery (TO, HSh), Graduate School of Medicine, Chiba University, Chiba and Department of Pathology, Faculty of Medicine, Mie University (MW), Mie, Japan
  • HIDEAKI SHIMADA
    From the Departments of Urology (HSu, KA, TI, TU, HI), Laboratory and Clinical Medicine (FN) and Academic Surgery (TO, HSh), Graduate School of Medicine, Chiba University, Chiba and Department of Pathology, Faculty of Medicine, Mie University (MW), Mie, Japan

収録刊行物

  • Journal of Urology

    Journal of Urology 171 (1), 182-186, 2004-01

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (4)*注記

もっと見る

キーワード

問題の指摘

ページトップへ